Cargando…

Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy

Triptolide (TPL) is a diterpenoid triepoxide with broad antitumor efficacy, while lack of mechanism of action, severe systemic toxicity, and poor water solubility of TPL limited its usage. To unveil the mechanism of action and improve the pharmaceutical properties of TPL, here we explored the molecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yanwen, Kong, Fanhua, Liu, Songyang, Liu, Xi, Pei, Dongni, Miao, Xiongying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477919/ https://www.ncbi.nlm.nih.gov/pubmed/34569906 http://dx.doi.org/10.1080/10717544.2021.1983072

Ejemplares similares

Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
por: Yu, Ling, et al.
Publicado: (2021)

Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects
por: Zhao, Xiaoli, et al.
Publicado: (2023)

Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes
por: Yuan, Zhi-xiang, et al.
Publicado: (2017)

Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment
por: Wang, Kunpeng, et al.
Publicado: (2021)

Transdermal delivery of triptolide–phospholipid complex to treat rheumatoid arthritis
por: Liu, Xin-Yi, et al.
Publicado: (2021)

Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy
por: Lin, Congcong, et al.
Publicado: (2017)

Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma
por: Zhao, Xiyue, et al.
Publicado: (2019)

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou, Xiaoju, et al.
Publicado: (2012)

Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
por: Ren, Shujing, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis
por: Chen, Gui, et al.
Publicado: (2015)

Chimeric Stimuli-Responsive Liposomes as Nanocarriers for the Delivery of the Anti-Glioma Agent TRAM-34
por: Naziris, Nikolaos, et al.
Publicado: (2021)

Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma
por: Li, Zhe, et al.
Publicado: (2021)

Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine
por: Sun, Rui, et al.
Publicado: (2022)

Mannosylated liposomes for targeted gene delivery
por: Kong, Fansheng, et al.
Publicado: (2012)

Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide
por: Shan, Qian-Qian, et al.
Publicado: (2019)

Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties
por: Gu, Yongwei, et al.
Publicado: (2018)

Mechanism underlying the effect of Pulsatilla decoction in hepatocellular carcinoma treatment: a network pharmacology and in vitro analysis
por: Liu, Kuijie, et al.
Publicado: (2023)

Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
por: Wei, Minyan, et al.
Publicado: (2015)

Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
por: Zhang, Wendian, et al.
Publicado: (2015)

Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling
por: Wang, Haiji, et al.
Publicado: (2016)

Chimeric apoptotic bodies functionalized with natural membrane and modular delivery system for inflammation modulation
por: Dou, Geng, et al.
Publicado: (2020)

The molecular pathogenesis of triptolide-induced hepatotoxicity
por: Hu, Yeqing, et al.
Publicado: (2022)

MicroRNAs as crucial mediators in the pharmacological activities of triptolide (Review)
por: Zhou, Kun, et al.
Publicado: (2021)

Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment
por: Ma, Weijie, et al.
Publicado: (2020)

Preparation and Optimization of Triptolide-Loaded Solid Lipid Nanoparticles for Oral Delivery with Reduced Gastric Irritation
por: Zhang, Cong, et al.
Publicado: (2013)

Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
por: Oh, Hea Ry, et al.
Publicado: (2016)

Transforming of Triptolide into Characteristic Metabolites by the Gut Microbiota
por: Peng, Ran, et al.
Publicado: (2020)

GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma
por: Li, Yanying, et al.
Publicado: (2022)

Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2021)

C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells
por: Li, Shu-Guang, et al.
Publicado: (2018)

Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma
por: Kong, Fanhua, et al.
Publicado: (2022)

Triptolide with hepatotoxicity and nephrotoxicity used in local delivery treatment of myocardial infarction by thermosensitive hydrogel
por: Wang, Kun, et al.
Publicado: (2023)

Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy
por: Zhang, Ping Na, et al.
Publicado: (2022)

Cardiomyocytic FoxP3 is involved in Parkin-mediated mitophagy during cardiac remodeling and the regulatory role of triptolide
por: Pan, Xi-Chun, et al.
Publicado: (2022)

Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade
por: Kong, Xiangying, et al.
Publicado: (2013)

SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma
por: Liu, Xiao, et al.
Publicado: (2016)

The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment
por: Yang, Encheng, et al.
Publicado: (2016)

Triptolide inhibits vascular endothelial growth factor-mediated angiogenesis in human breast cancer cells
por: Liu, Huantao, et al.
Publicado: (2018)

Triptolide-mediated downregulation of FLIP(S) in hepatoma cells occurs at the post-transcriptional level independently of proteasome-mediated pathways
por: Liu, Weixia, et al.
Publicado: (2022)

Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial–mesenchymal transition
por: Deng, Qiu-di, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kri9jsbs0l04qgl9cdenv24j8j